Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-5.05	34.06	35.87
Graham Fair Price	3.15	7.41	7.18
PEG	192.26	2.48	0.85
Price/Book	-11.88	1.18	1.34
Price/Cash Flow	-64.74	-12.70	36.03
Prices/Earnings	-13.82	9.55	11.08
Price/Sales	-16.39	1.95	2.33
Price/FCF	-64.74	-12.70	36.03
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	4.74	0.10	0.10
Operating Margin	-5.63	0.06	0.06
ROA	4.36	0.01	0.01
ROE	0.03	0.03	2.25
ROIC	0.02	0.02	-10.60
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.25	-0.27	-6.79
Dividends QOQ	1.39	2.11	52.11
EBIT QOQ	0.29	0.01	-94.77
EPS QOQ	0.13	0.04	-70.51
FCF QOQ	-0.62	-3.55	-473.09
Revenue QOQ	-0.27	0.08	-71.80
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	34.94	25.42	-27.24
Days Sales Outstanding (DSO)	130.46	111.83	-14.28
Inventory Turnover	2.58	3.54	37.44
Debt/Capitalization	0.39	0.44	12.25
Quick Ratio	0.89	1.41	59.02
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	8.70	9.72	11.73
Cash	1.42	4.04	183.66
Capex	-0.01	0.10	639.09
Free Cash Flow	0.32	-0.83	154.91
Revenue	5.01	5.38	7.51
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.50	1.56	4.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.30	8.31	93.21
Naive Interpretation	Member

06 - Financial Health · Weak

Rating